Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 112,487 $ 128,273
Accounts receivable 2,347 583
Accounts receivable due from related parties 1,316 1,377
Prepaid expenses and other current assets 4,670 3,458
Total 120,820 133,691
Property, plant and equipment, net 116,041 115,856
Deferred engineering costs 31,650 18,000
Other non-current assets 11,503 9,276
Total assets 280,014 276,823
Current liabilities:    
Accounts payable 3,255 11,462
Accrued liabilities 23,888 39,101
Other current liabilities 0 1,735
Total 27,143 52,298
Asset retirement obligation 649 638
Total liabilities 27,792 52,936
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and zero shares outstanding 28 0
Common stock, $0.01 par value, 400,000,000 authorized: 228,421,102 and 222,749,220 shares outstanding 2,072 2,043
Additional paid-in capital 603,420 549,958
Accumulated deficit (353,298) (328,114)
Total stockholders’ equity 252,222 223,887
Total liabilities and stockholders’ equity $ 280,014 $ 276,823